The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Lithium: Bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 1×
“Drevets et al. (1997) observed a 40% reduction in subgenual prefrontal cortex volumes in familial mood disorder subjects.”
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · cited 1×
“These results have been replicated in more than one study (Badner and Gershon, 2002).”
Pet imaging of serotonin 1A receptor binding in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., & Mathis, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00189-4 · Cited by 666 · cited 1×
“Such decreases were particularly significant in bipolar depressive and unipolar patients (Drevets et al., 1999).”
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649 · cited 2×
“In a clinical study, Moore et al. (2000a) reported that the administration of therapeutic doses of lithium exerted regenerative neurostructural (increased gray matter volume in brain) and neurochemical (increased levels of N-acetyl-aspartate (NAA), a marker of neuronal viability and function)…”
Lithium delays progression of amyotrophic lateral sclerosis
Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708022105 · Cited by 550
Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder
Frank, E., Swartz, H. A., & Kupfer, D. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00969-0 · Cited by 521 · cited 2×
“induced by bipolar illness episodes (Frank et al., 2000; Hlastala et al., 2000).”
Belmaker, R. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035354 · Cited by 473
The functional neuroanatomy of mood disorders
Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379 · cited 1×
“It remains to be elucidated whether these findings represent neurodevelopmental abnormalities; disease progression involving the loss or atrophy of neurons and glia; or the effects of biochemical changes (Soares and Mann, 1997; Manji et al., 1999, 2000).”
Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341 · cited 1×
“…pharmacological or genetic inhibition of GSK-3β in rodents recapitulates someof the effects of lithium on behaviour (Beaulieu et al., 2004; O'Brien et al., 2004), whereas overexpression of GSK-3β reproduces behavioural correlates of hyperactivity andmania in mice (Prickaerts et al., 2006).”
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · cited 1×
“Other studies showed that inhibitory phosphorylation of GSK-3 was significantly increased by different concentrations of 5-HT inmice brain (Li et al., 2004), and identify GSK-3β signalling as an important pathway through which brain 5-HT deficiency induces abnormal behaviour patterns (Beaulieu et…”
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
Benedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195 · cited 1×
“One SNP (−50T/C) is common and particularly interesting as it falls into the effective promoter region of the gene coding forGSK-3β (Rus et al., 2001; Lenoxet al., 2002; Benedetti et al., 2004a,b).”
Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184 · cited 1×
“In patients affected by bipolar disorder, Benedetti et al. (2005) reported that homozygotes of themutant allele of theGSK-3β promoter (−50T/C) SNPwere associatedwith a later onset of bipolar illness and better antidepressant effects on total sleep deprivation.”
Future of genetics of mood disorders research
Merikangas, K. R., Chakravarti, A., Moldin, S. O., Araj, H., Blangero, J., Burmeister, M., Crabbe, J. C., Depaulo, J. R., Foulks, E., Freimer, N. B., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01471-3 · Cited by 128 · cited 1×
“Family studies using currently accepted diagnostic criteria have repeatedly demonstrated a 10- to 20-fold increase in the risk of bipolar illness amongfirst-degree relatives of index cases, when compared with relatives of controls (Tsuang et al., 1985; Merikangas et al., 2002; Glahn et al., 2004).”
Kleindienst, N., & Greil, W. (2000) · Neuropsychobiology · doi:10.1159/000054844 · Cited by 123
Cited by
Potential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Dudev, T., & Lim, C. (2014) · Chemical Reviews · doi:10.1021/cr4004665 · Cited by 451
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Cadherins and neuropsychiatric disorders
Redies, C., Hertel, N., & Hübner, C. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.020 · Cited by 257
Lithium: the pharmacodynamic actions of the amazing ion
Brown, K. M., & Tracy, D. K. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312471963 · Cited by 140
“2005] and, more speculatively, has been considered as a possible therapeutic agent for treating chronic neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s diseases [Marmol, 2008; Dudev and Lim, 2011].”
BackgroundResult
Metadata
- Authors
- Marmol, F.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 32
- Issue
- 8
- Pages
- 1761-1771
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2065684604
- Cited by
- 174
- References
- 16
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.